A Trial for Relapsed Multiple Myeloma Patients (Isatuximab-dexamethasone)
NCT04965155
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Relapsed Multiple Myeloma
Interventions
DRUG:
Isatuximab-dexamethasone
Sponsor
EMN Trial Office S.r.l. Impresa Sociale